About 1.5 million people died from tuberculosis in 2020, up from 1.4 million in 2019, and reporting of cases has dropped substantially.
A clinical trial in the Netherlands found that an antimicrobial stewardship intervention safely reduced broad-spectrum antibiotic use in patients hospitalized with moderately severe pneumonia, Dutch researchers reported yesterday in The Lancet Infectious Diseases.
The data show that 1.2 million fewer people have been diagnosed and treated for TB in 2021 than in 2019.
New data presented today indicate that a shorter treatment regimen for highly drug-resistant forms of tuberculosis (TB) remains highly effective with reduced doses of one of its components.
A Wellcome report yesterday says more research is needed on drug-resistant bacterial infections (DRIs), but current data indicate that DRIs can be more likely to occur—and have more serious ramifications—in people with health conditions like cancer or who have received extensive treatment such as surgery.
The London School of Hygiene and Tropical Medicine (LSHTM) announced today that it is partnering with Johnson & Johnson (J&J) to launch a center focused on research into antimicrobial resistance and tuberculosis (TB).
The World Health Organization (WHO) today issued an update to its consolidated guidelines on the detection of tuberculosis (TB) and drug-resistant TB.
Following China's 70-year battle against malaria, the World Health Organization (WHO) today announced that the country has been awarded a malaria-free certification. In a statement, the WHO said that the achievement is notable, given that China reported about 30 million cases each year in the 1940s.
The Centers for Disease Control and Prevention (CDC) said this week that it's investigating a cluster of tuberculosis (TB) infections in patients who've recently undergone spinal surgery that used a single lot of a bone repair product.
US lawmakers today re-introduced a bill to reinvigorate the antibiotic development market.
